Back to Results
First PageMeta Content
Pfizer / Medicine / Pharmacology / Pharmaceutical sciences / Medroxyprogesterone 17-acetate / Progestin / Combined injectable contraceptive / Menorrhagia / Medroxyprogesterone / Hormonal contraception / Progestagens / Depo-Provera


Sayana Press Clinical Brief
Add to Reading List

Document Date: 2014-07-03 17:23:23

Open Document

File Size: 163,55 KB

Share Result on Facebook

City

Geneva / Nicosia / Los Angeles / New York / /

Company

Pfizer Inc. / HIV / Sayana Press / Pharmacia & Upjohn Company / Depo-Provera / ADMINISTRATION AND DOSAGE Sayana Press / CONTRAINDICATIONS AND SIDE EFFECTS Sayana Press / When Sayana Press / BD. / /

Continent

Asia / Europe / /

Country

United States / Brazil / Canada / Singapore / /

IndustryTerm

injection site / expert / autodisable injection device / /

MedicalCondition

headaches / granuloma / pain / /

MedicalTreatment

contraception / contraceptive method / ovulation suppression / /

Organization

World Health Organization / Convenient administration / Discreet administration / /

Person

D. Pharmacokinetics / /

Position

Physician / Archer / /

Product

UnijectTM injection / Depo-subQ provera / Depo-Provera / medroxyprogesterone acetate / Uniject / /

ProvinceOrState

California / /

RadioStation

Kaunitz AM / /

Region

South America / North America / /

Technology

pharmacokinetics / pharmacodynamics / /

URL

www.who.int/reproductivehealth/publications/family_planning/9789241563888/en/index.html / www.who.int/mediacentre/news/notes/2012/contraceptives_20120216/en/index.html / http /

SocialTag